Filing Details

Accession Number:
0001104659-22-091183
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-15 15:45:56
Reporting Period:
2022-08-11
Accepted Time:
2022-08-15 15:45:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1868734 Cincor Pharma Inc. CINC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1245624 James Healy C/O Sofinnova Investments, Inc.
3000 Sand Hill Road, Bldg. 4, Suite 250
Menlo Park CA 94025
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-11 500,000 $30.00 6,073,949 No 4 P Indirect By Sofinnova Venture Partners X, L.P.
Common Stock Acquisiton 2022-08-11 6,000 $30.00 6,000 No 4 P Indirect By Sofinnova Synergy Master Fund, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Sofinnova Venture Partners X, L.P.
No 4 P Indirect By Sofinnova Synergy Master Fund, LP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 29,411 Direct
Footnotes
  1. The shares are directly held by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X"), the general partner of SVP X, may be deemed to have sole voting and dispositive power over such shares. The Reporting Person is a managing member of SM X and may be deemed to share voting and dispositive power over the shares held by SVP X. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
  2. The shares are directly held by Sofinnova Synergy Master Fund, LP (the "Synergy Fund"). Sofinnova Synergy Fund GP, LLC (the "Synergy Fund GP"), the general partner of the Syngery Fund, may be deemed to have sole voting and dispositive power over such shares. The Reporting Person is a managing member of the Synergy Fund GP and may be deemed to share voting and dispositive power over the shares held by the Synergy Fund. The Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.